Medical University of South Carolina
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medical University of South Carolina sits in the top decile of US sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count).
Medical University of South Carolina: 755 sponsored US clinical trials, 142 recruiting.
Medical University of South Carolina sponsors 755 registered US clinical trials on ClinicalTrials.gov, 142 of them currently recruiting, and 520 completed. 66 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 15 trials.
Top-decile sponsor footprint
Medical University of South Carolina ranks in the top decile of sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
520 of 580 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
755 total, page 8 of 16
EEG Synchronized TMS Trial for Depression
NCT03421808
Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)
NCT02633163
Stress Reactivity Among African American Breast Cancer Survivors
NCT03881085
Music's Effects on Anxiety During Epidural Placement
NCT03844659
Enhancing Self Regulation Among Smokers
NCT04161144
Improving Quality of Care in Child Mental Health Service Settings
NCT03305458
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
NCT03538444
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
NCT03624517
QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt
NCT03576768
Sensory Stimulation During CIMT
NCT03558230
Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders
NCT03732248
Respiratory Muscle Strength Training in Presbyphonia
NCT03557775
iTBS Methods and Motor Cortex Excitability
NCT03584438
Clinical Outcomes of a Nationwide, Naturalistic E-Cig Trial (CONNECT)
NCT03453385
Quadratus Lumborum Block for Analgesia Following Hip Arthroscopy
NCT03557125
Nicotine TMS EFT Smoking Pilot Study
NCT03579953
Quadratus Lumborum Versus Transversus Abdominis Plane Nerve Block: A Comparison Study
NCT03490357
Peer Social Support During In Vivo Exposure for PTSD
NCT03485391
Impact of Exclusive Use of Low Nicotine Cigarettes on Compensatory Smoking
NCT03311646
taVNS in Mild to Moderate Parkinson's Disease
NCT04157621
Self-Management for Youth and Families Living With SCD - SMYLS
NCT03585543
Functional Connectivity & Stimulation-enhanced Therapy Post Stroke
NCT03473808
Anti-platelet + Pembro for H&N Tumors
NCT03245489
Safety and Efficacy of the Tao Facemask for Positive Pressure Ventilation in the Patients With Significantly Elevated BMIs
NCT03473366
Quadratus Lumborum Block Versus Transversus Abdominus Plane Block for Pain Management After Donor Nephrectomy
NCT03476850
Evaluating Barriers to Stroke Screening and Prevention in Children With Sickle Cell Disease
NCT03621826
Building a Renewed ImaGe After Head & Neck Cancer Treatment
NCT03518671
Pilot Study of the HWL Program
NCT03439579
Gait Mate: Examining Neural Networks Engaged During Lower Extremity Movement in the MRI
NCT03604367
LAM Pilot Study With Imatinib Mesylate
NCT03131999
RESP-FIT: Technology-Enhanced Self-Management in COPD
NCT03652662
Comparison of 0.1 and 0.05mg Intrathecal Morphine for Post-cesarean Analgesia.
NCT03427463
Care Coordination Approaches to Learning Lupus Self-management
NCT04400240
Accelerated rTMS for the Reduction of Nicotine Craving
NCT03352609
Bounce Back Now: A Low-Cost Intervention to Facilitate Post-Disaster Recovery
NCT03403738
Rhinoplasty Scar Comparison
NCT03748459
The Effect of Povidone-iodine Ophthalmic Surgical Prep Solution on Respiration in Children Undergoing Strabismus Surgery With General Anesthesia.
NCT03349515
Brain Stimulation For Cancer Smokers
NCT03419741
Progesterone for Cannabis Withdrawal
NCT03430050
Neuroscience-Informed Treatment Development for Adolescent Alcohol Use
NCT03238300
Increasing Caregiver Engagement in Juvenile Drug Courts
NCT03051997
Circulating Tumor DNA As Liquid Biopsy in Patients with Stage IV Solid Tumors, a Feasibility Study At MUSC HCC
NCT03302325
mHealth Medication Safety Intervention
NCT03247322
taVNS Paired With Bottle Feeding in Infants Failing Oral Feeds
NCT04643808
Gabapentin for Bipolar & Cannabis Use Disorders
NCT03334721
Perinatal Opioid Use
NCT04049032
A "Window Trial" on Boswellia for Breast Cancer Primary Tumors
NCT03149081
The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus
NCT03193216
A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors
NCT03172832
Partners at Meals - Respite Care and Home (PAM)
NCT03622814
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 104 |
| Phase 2 | 124 |
| Phase 3 | 23 |
| Phase 4 | 43 |
Therapeutic Areas
What is open in the Medical University of South Carolina pipeline
142 recruiting of 755 indexed (19% open); 520 completed (69%).
Phase mix: 66 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Stroke (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medical University of South Carolina: open-pipeline peers nationwide
Peers matched on 755 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 755 trials (± recruiting share)
- University of California, San Diego · 775 trials · 18% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Spaulding Rehabilitation Hospital · 19% recruiting · 101 trials
- Ipsen · 19% recruiting · 85 trials
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
Related
What to do with this Medical University of South Carolina page
755 registered trials is a research-attention snapshot, not an endorsement of Medical University of South Carolina or any single study.
- 142 of Medical University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Medical University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Medical University of South Carolina pipeline card: 755 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.